ClinicalTrials.gg

Drug

Indole-3-carbinol clinical trials

studies test it
5
open now
1
in phase 3
1
first study started
2002

Keep track of what changes. Save the indole-3-carbinol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Other names

Studies by the year they started

5 studies that test it; most in 2002 (1)

Studies that test indole-3-carbinol, by start year
YearStudies
20021
20041
20091
20181
20251

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 5

Masonic Cancer Center, University of Minnesota (1) · University of Kansas Medical Center (1) · University of Kansas (1) · Alcea (1) · University of Wisconsin, Madison (1)

Often tested with

Tested in the same studies.

Silybin (1)

Studies

Open first, then newest update. How each study uses indole-3-carbinol is read from its arms, and is right about nine times in ten.

Testing it · 5

Given in every arm · 1 — indole-3-carbinol is usual care beside what is tested

Codes

What other systems call indole-3-carbinol · ClinicalTrials.gg INT002651

  • MeSH (NLM) C016517indole-3-carbinolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) C11E72455FINDOLE-3-CARBINOLConfirmed FDA, NLM, Wikidata
  • RxNorm 2598119One source FDA
  • Wikidata Q1770257indole-3-carbinolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1135Indole-3-CarbinolOne source FDA
  • DrugBank DB12881One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.